Orbon, 24, tested positive for di-hydroxy-LGD-4033, a metabolite of LGD-4033, as the result of an in‐competition urine sample she provided at the Senior Team Trials on January 19, 2019. LGD‐4033 is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the World Karate Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.